CDMO Business Our Offering

Manufacturing (APIs,HPAPI & Ph. Int.)

We manufacture Small API Molecule, HPAPI and pharmaceutical intermediates under cGMP

Strategically located in 3 continents -Europe, Asia, and America- our 6 full cGMP multipurpose manufacturing sites provide a total reaction volume of 1046 m³. From a few kilos to several metric tons (MT), we guarantee perfect solutions and flexibility for chemical and pharmaceutical intermediates or APIs.

Our sites are equipped with state-of-the art facilities to assure a smooth, safe, and optimized scale-up process.

We work with a wide range of chemical reactions and products while performing the final stages of manufacturing in a pharmaceutical environment. Our pharmaceutical approach to chemical manufacturing suiting ISO8 for API handling (class 100,000 clean rooms for the last steps of synthesis) ensures full control of our products and processes according to the strictest quality standards.

Scalability

The diversity and flexibility of our equipment allows working with small-scale (kilo lab) and large-scale commercial productions, thus ensuring similar equipment trains at all stages to minimize potential scale-up problems.

Our extensive know-how and experience allow us to offer our customers the best alternative according to their quantity requirements at any stage of the project. A wide range of reactors (from 200l up to 10,000l) also allow us to provide a great flexibility in terms of scalability and batch size, providing our customers with a better life-cycle management of their products.

Lean management structure

With a very business-oriented model and accessible leadership, we make fast decisions to introduce new technologies, as well as designing models of partnerships to support the investment required to ensure the success of our customers' projects.

High Quality Standards

As a Global Organization, we operate under cGMPs at all our sites and at all scales.

Our sites are inspected on a regular basis by different health authorities (FDA, European and National Authorities, PMDA...)

100% Inspections passed successfully and smoothly without any significant findings, maintaining Esteve immaculate track record.

READ MORE